170 related articles for article (PubMed ID: 2530011)
1. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Linz W; Schölkens BA; Ganten D
Clin Exp Hypertens A; 1989; 11(7):1325-50. PubMed ID: 2530011
[TBL] [Abstract][Full Text] [Related]
2. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.
Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA
Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756
[TBL] [Abstract][Full Text] [Related]
3. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
[TBL] [Abstract][Full Text] [Related]
4. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
[TBL] [Abstract][Full Text] [Related]
5. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition.
Grimm D; Kromer EP; Böcker W; Bruckschlegel G; Holmer SR; Riegger GA; Schunkert H
J Hypertens; 1998 Sep; 16(9):1345-55. PubMed ID: 9746122
[TBL] [Abstract][Full Text] [Related]
6. The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension.
Matsubara BB; Matsubara LS; Franco M; Padovani JC; Janicki JS
Int J Exp Pathol; 1999 Apr; 80(2):97-104. PubMed ID: 10469264
[TBL] [Abstract][Full Text] [Related]
7. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril.
Linz W; Schölkens BA
Br J Pharmacol; 1992 Apr; 105(4):771-2. PubMed ID: 1324047
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
Mohabir R; Young SD; Strosberg AM
J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
10. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats.
Zierhut W; Zimmer HG; Gerdes AM
Circ Res; 1991 Sep; 69(3):609-17. PubMed ID: 1714799
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
Linz W; Henning R; Schölkens BA
J Hypertens Suppl; 1991 Dec; 9(6):S400-1. PubMed ID: 1840203
[No Abstract] [Full Text] [Related]
13. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a non-antihypertensive dose of ramipril on the plasma and tissue renin-angiotensin system in 27 TGR (mRen2) rats].
Grima M; Anjuère J; Ingert C; Coquard C; Steger J; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):805-12. PubMed ID: 11575208
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis.
Linz W; Wiemer G; Schaper J; Zimmermann R; Nagasawa K; Gohlke P; Unger T; Schölkens BA
Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):89-97. PubMed ID: 7494560
[TBL] [Abstract][Full Text] [Related]
17. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reduction.
Schölkens BA; Linz W; Martorana PA
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S26-30. PubMed ID: 1725038
[TBL] [Abstract][Full Text] [Related]
18. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
Clauser E
Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction.
Linz W; Wiemer G; Schmidts HL; Ulmer W; Ruppert D; Schölkens BA
Clin Exp Hypertens; 1996 Jul; 18(5):691-712. PubMed ID: 8781754
[TBL] [Abstract][Full Text] [Related]
20. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
